Development of Immunosorbents for apoB-Containing Lipoproteins Apheresis
- 1 June 1995
- journal article
- clinical trial
- Published by Wiley in Artificial Organs
- Vol. 19 (6) , 500-505
- https://doi.org/10.1111/j.1525-1594.1995.tb02369.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter studyAtherosclerosis, 1992
- Immunosorbent for Selective Removal of Lipoprotein (a) from Human Plasma: In Vitro StudyArtificial Organs, 1991
- Lipoprotein(a). A unique risk factor for atherothrombotic disease.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Effectiveness of Diet and Drugs in the Treatment of Patients with Elevated Lp(a) LevelsPublished by Elsevier ,1990
- Experience with Low-Density Lipoprotein Apheresis by Polyclonal and Monoclonal Anti-Apolipoprotein B Antibodies and by Dextran Sulfate CellulosePublished by S. Karger AG ,1990
- Removal of low-density lipoproteins in patients by extracorporeal immunoadsorptionThe American Journal of Medicine, 1986
- Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresisAtherosclerosis, 1986
- Regression der Koronarsklerose bei familiärer Hypercholesterinämie IIa durch spezifische LDL-AphereseDeutsche Medizinische Wochenschrift (1946), 1986
- Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
- APPLICATION OF SPECIFIC EXTRACORPOREAL REMOVAL OF LOW DENSITY LIPOPROTEIN IN FAMILIAL HYPERCHOLESTEROLAEMIAThe Lancet, 1981